Assessing the Safety and Efficacy of Lamotrigine as Anti-myotonic Agent in Myotonic Dystrophy Type 1 (DM1): A Longitudinal, Open-Label, Pilot Study. - Risi, Barbara; Ait Allali, Nesaiba; Cotti Piccinelli, Stefano; Caria, Filomena; Damioli, Simona; Labella, Beatrice; Bertella, Enrica; Giovanelli, Giorgia; Garofali, Francesca; Margollicci, Giuseppina; Carugati, Roberto; Ferullo, Lucia; et al. (Neurology & Therapy, 2025)